Meeting
2023 ASCO Gastrointestinal Cancers Symposium
A glimpse into the future of hepatocellular carcinoma (HCC): Predicting the future incidence based on the current epidemiological data.
Authors
Sri Harsha Tella
Mayo Clinic, Rochester, MN;
Sri Harsha Tella , Mikolaj Wieczorek , David Hodge , Amit Mahipal
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session B: Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract
Track
Pancreatic Cancer,Hepatobiliary Cancer,Neuroendocrine/Carcinoid,Small Bowel Cancer
Sub Track
Other
Citation
J Clin Oncol 41, 2023 (suppl 4; abstr 615)
DOI
10.1200/JCO.2023.41.4_suppl.615
Abstract #
615
Poster Bd #
G8
Abstract Disclosures
Similar Posters
First Author: Ephrem Tadele Sedeta
Poster
2022 ASCO Gastrointestinal Cancers Symposium
Bridge-to-transplant stereotactic body radiation therapy in patients with hepatocellular carcinoma and advanced cirrhosis.
First Author: Mohammad Hissourou
Poster
2021 Gastrointestinal Cancers Symposium
The lines of loco-regional therapies received and the healthcare economic burden of patients newly diagnosed with hepatocellular carcinoma in the United States.
First Author: Brian Seal
Poster
2020 Gastrointestinal Cancers Symposium
Economic burden and patterns of care in patients with advanced hepatocellular carcinoma.
First Author: Abdalla Aly